Fluzone Preservative-free

Company
Sanofi Pasteur

Approval Status
Approved September 2002

Treatment for
Influenza immunization in infants

Areas
Immune System , Pediatrics

The preservative-free formulation of the Fluzone Influenza Virus Vaccine was approved in September 2002 to immunize high-risk and normal infants, aged six months to 35 months.

Fluzone is also available in its non-preservative-free formulation for pediatric and adult patients.

For further information about Fluzone, visit the Aventis Pasteur vaccine product web site at www.vaccineshoppe.com.

Fluzone Preservative-free Drug Information

The Fluzone Preservative-free drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top